ArticleOncoTargets and therapy2016

Observational cohort study focused on treatment continuity of patients administered XELOX plus bevacizumab for previously untreated metastatic colorectal cancer.

Masahito Kotaka et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.